Literature DB >> 17993048

An obese female with Prader-Willi syndrome and daytime sleepiness.

Mary H Wagner1, Richard B Berry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17993048      PMCID： PMC2045708     

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  8 in total

1.  Cataplexy in the Prader-Willi syndrome.

Authors:  E S Tobias; J L Tolmie; J B P Stephenson
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

2.  Hypocretin deficiency in Prader-Willi syndrome.

Authors:  S Nevsimalova; J Vankova; I Stepanova; E Seemanova; E Mignot; S Nishino
Journal:  Eur J Neurol       Date:  2005-01       Impact factor: 6.089

3.  Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).

Authors:  Maria E Craig; Christopher T Cowell; Pontus Larsson; William B Zipf; Edward O Reiter; Kerstin Albertsson Wikland; Michael B Ranke; David A Price
Journal:  Clin Endocrinol (Oxf)       Date:  2006-08       Impact factor: 3.478

4.  Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment.

Authors:  D A M Festen; A W de Weerd; R A S van den Bossche; K Joosten; H Hoeve; A C S Hokken-Koelega
Journal:  J Clin Endocrinol Metab       Date:  2006-09-26       Impact factor: 5.958

5.  Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome.

Authors:  Jennifer Miller; Janet Silverstein; Jonathan Shuster; Daniel J Driscoll; Mary Wagner
Journal:  J Clin Endocrinol Metab       Date:  2005-11-29       Impact factor: 5.958

6.  Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors.

Authors:  R Manni; L Politini; L Nobili; F Ferrillo; C Livieri; E Veneselli; R Biancheri; M Martinetti; A Tartara
Journal:  Clin Neurophysiol       Date:  2001-05       Impact factor: 3.708

7.  The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome.

Authors:  Rolf Fronczek; Gert Jan Lammers; Rawien Balesar; Unga A Unmehopa; Dick F Swaab
Journal:  J Clin Endocrinol Metab       Date:  2005-06-28       Impact factor: 5.958

Review 8.  Sleep and breathing in Prader-Willi syndrome.

Authors:  Gillian M Nixon; Robert T Brouillette
Journal:  Pediatr Pulmonol       Date:  2002-09
  8 in total
  2 in total

Review 1.  Evidence-based recommendations for the assessment and management of sleep disorders in older persons.

Authors:  Harrison G Bloom; Imran Ahmed; Cathy A Alessi; Sonia Ancoli-Israel; Daniel J Buysse; Meir H Kryger; Barbara A Phillips; Michael J Thorpy; Michael V Vitiello; Phyllis C Zee
Journal:  J Am Geriatr Soc       Date:  2009-05       Impact factor: 5.562

2.  Weight control and behavior rehabilitation in a patient suffering from Prader Willi syndrome.

Authors:  Rosaria Di Lorenzo; Sara Sberveglieri; Donatella Marrama; Giulia Landi; Paola Ferri
Journal:  BMC Res Notes       Date:  2016-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.